Middle Of The Night Insomnia Press Articles
Shape - New snooze solution
Posted by admin / Under Middle Of The Night InsomniaMarch 1, 2012 --
Millions of Americans turn to pills at least occasionally to help them nod off (56 million scripts for insomnia drugs are filled each year),...
Internal Medicine News - FDA approves low-dose zolpidem for insomnia
Posted by admin / Under Middle Of The Night InsomniaDecember 1, 2011 --
A low-dose sublingual formulation of zolpidem tartrate is the first agent to be approved to treat insomnia characterized by...
Business Wire - Phase 2 Study of SKP-1041 for Sleep Maintenance Insomnia Shows Significant Reduction of Mid-Night Awakenings without Next-Day Cognitive Impairment
Posted by admin / Under Middle Of The Night InsomniaJune 15, 2011 -- Somnus Thera SKP1041 delayed-delivery zaleplon Phase 2 data meets all endpoints presented at APSS SLEEP2011: allows normal early deep sleep,...
Business Wire - Somnus Therapeutics Completes Successful Phase 2 Study of SKP-1041 for Sleep Maintenance Insomnia
Posted by admin / Under Middle Of The Night InsomniaJune 1, 2011 -- Somnus will present Phase 2 data at APSS SLEEP in June for its bedtime formulation of zaleplon that addresses the top insomnia need: maintaining...
Business Wire - Somnus Therapeutics Awarded QTDP Grant for Clinical Trials of SKP-1041 Sleep Maintenance Insomnia Therapy
Posted by admin / Under Middle Of The Night InsomniaNovember 4, 2010 -- Somnus Therapeutics gets $245,000 QTDP Grant to support clinical trials of delayed-release zaleplon formulation taken at bedtime to prevent middle...
